Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Valsartan Alone

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients with uncomplicated, essential hypertension~Exclusion Criteria:~* Severe hypertension~* History of stroke, myocardial infarction, heart failure, chest pain, abnormal heart rhythm~* Liver, kidney, or pancreas disease~* Insulin dependent diabetes~* Allergy to certain medications used to treat high blood pressure~Other protocol-defined exclusion criteria may apply.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: None

Based on this trial design, predict the completion outcome and termination type (if applicable).